Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice

Chronobiology International

Volumn 25, Issue 4, 2008, Pages 533-547

  Dridi, Dorra ^a,b   Ben Attia, Mossadok ^c   Sani, Mamane ^c   Djebli, Nassim ^b   Sauvage, François Ludovic ^d   Boughattas, Naceur A ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF LIMOGES   (France)

^c University of Carthage   (Tunisia)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Chronopharmacokinetics; Circadian rhythm; Desloratadine; Loratadine; Mice

Indexed keywords

DESLORATADINE; LORATADINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHRONOBIOLOGY; CHRONOPHARMACOKINETICS; CIRCADIAN RHYTHM; CIRCADIAN TIME EFFECT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT DARK CYCLE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PHARMACOKINETICS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ALLERGIC AGENTS; AREA UNDER CURVE; CALIBRATION; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; LORATADINE; MALE; MICE; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

MUS;

EID: 47249116111     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.1080/07420520802257646     Document Type: Article

References (69)

1. Barret A. (1998 November 30). New teeth for old patents. Business Week 92-94.
2. Belanger PM. (1993). Chronopharmacology in drug research and therapy. Adv. Drug. Res. 24:1-80.
3. Boughattas NA, Lévi F, Hecquet B, Lemaigre G, Roulon A, Fournier C, Reinberg A. (1988). Circadian time dependence of murine tolerance for carboplatin. Toxicol. Appl. Pharmacol. 96:233-247.
4. Boughattas NA, Lévi F, Fournier C, Lemaigre G, Roulon A, Hecquet B, Mathé G, Reinberg A. (1989). Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane (trans-1) oxalatoplatinum (II) in mice. Cancer Res. 49:3362-3368.
5. Boughattas NA, Hecquet B, Fournier C, Bruguerolle B, Trabelsi H, Bouzouita K, Omrane B, Lévi F. (1994). Comparative pharmacokinetics of oxaliplatin (L-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing time. Biopharm. Drug Dispos. 15:761-773.
6. Boughattas NA, Li XM, Filipski J, Lemaigre G, Filipski E, Bouzouita K, Belhadj O, Lévi F. (1996). Modulation of cisplatin chronotoxicity related to reduced glutathione in mice. Hum. Exp. Toxicol. 15:563-572.
7. Boughattas NA, Ben Attia M, Ixart G, Lemaigre G, Mechkouri M, Reinberg A. (2002). Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats. Chronobiol. Int. 19:1121-1136.
8. Boulamery A, Kadra G, Simon N, Besnard T, Bruguerolle B. (2007). Chronopharmacokinetics of imipenem in the rat. Chronobiol. Int. 24:961-968.
9. Brannan MD, Reidenberg P, Radwanski E, Shneyer L, Lin CC, Cayen MN, Affrime MB. (1995). Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations. Clin. Pharmacol. Ther. 58:269-278.
10. Bruguerolle B. (1998). Chronopharmacokinetics: Current status. Clin. Pharmacokinet. 35:83-94.
11. Bruguerolle B, Lemmer B. (1993). Recent advances in chronopharmacokinetics: methodological problems. Life Sci. 52:1809-1824.
12. Bruguerolle B, Prat M. (1989). Temporal variations in the erythrocyte permeability to bupivacaine, etidocaine and mepivacaine in mice. Life Sci. 45:2587-2590.
13. Bruguerolle B, Boulamery A, Simon N. (2008). Biological rhythms: A neglected factor of variability in pharmacokinetic studies. J. Pharm. Sci. 97:1099-1108.
14. Burioka N, Sasaki T. (1996). Chronopharmacology and chronotherapy for asthma by using PEF. Nippon Rinsho 54:2956-2961.
15. Burioka N, Miyata M, Endo M, Fukuoka Y, Suyama H, Nakazaki H, Igawa K, Shimizu E. (2005a). Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy. Chronobiol. Int. 22: 383-390.
16. Burioka N, Takata M, Okano Y, Ohdo S, Fukuoka Y, Miyata M, Takane H, Endo M, Suyama H, Shimizu E. (2005b). Dexamethasone influences human clock gene expression in bronchial epithelium and peripheral blood mononuclear cells in vitro. Chronobiol. Int. 22:585-590.
17. Burioka N, Takata M, Endo M, Miyata M, Takeda K, Chikumi H, Tomita K, Fukuoka Y, Nakazaki H, Sano H, Shimizu E. (2007). Treatment with beta2-adrenoceptor agonist in vivo induces human clock gene, Per1, mRNA expression in peripheral blood. Chronobiol. Int. 24:183-189.
18. Cloutier M, Labrecque G, Rivard GB. (1993). Chronopharmacology of albuterol in hospitalized asthmatic children. Chronobiol. Int. 10:290-297.
19. Cui Y, Sugimoto K, Araki N, Sudoh T, Fujimura A. (2005). Chronopharmacology of morphine in mice. Chronobiol. Int. 22:515-522.
20. De Prins J, Waldura J. (1993). Sightseeing around the single cosinor. Chronobiol. Int. 10:395-400.
21. Dridi D, Boughattas NA, Aouam K, Reinberg A, Ben Attia M. (2005). Circadian time-dependent differences in murine tolerance to the antihistaminic agent loratadine. Chronobiol. Int. 22:499-514.
22. Gabrielsson J, Weiner D. (2000). Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, 3rd edn. Stockholm, Sweden: Swedish Pharmaceutical Press, pp. 141-153.
23. Han KS, Lee MG. (1998). Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in rats. J. Pharm. Pharmacol. 50:767-774.
24. Haus E. (2007a). Chronobiology in the endocrine system. Adv. Drug Deliv. Rev. 59:985-1014.
25. Haus E. (2007b). Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv. Drug Deliv. Rev. 59:966-984.
26. Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rationale and design of the MAPEC study. Chronobiol. Int. 24: 749-775.
27. Hermida RC Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007). Chronotherapy of hypertension: Administation-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Res. 59:923-939.
28. Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S, Zampaglione N. (1987). Pharmacokinetics and dose proportionality of loratadine. J. Clin. Pharmacol. 27:694-698.
29. Hirao J, Arakawa S, Watanabe K, Ito K, Furukawa T. (2006). Effects of restricted feeding on daily fluctuations of hepatic functions including P450 monooxygenase activities in rats. J. Biol. Chem. 281: 3165-3171.
30. Holzberg D, Albrecht U. (2003). The circadian clock: a manager of biochemical processes within the organism. J. Neuroendocrinol. 15:339-343.
31. Katchen B, Cramer J, Chung M, Gural R, Hilbert J, Luc V, Mortizen V, D'Sousa R, Symchowicz S, Zampaglione N. (1985). Disposition of 14C-SSCH29851 in humans. Ann. Allergy 55:393-395.
32. Kay GG, Harris AG. (1999). Loratadine: A non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin. Exp. Allergy 29(Suppl. 3):147-150.
33. Kosoglou T, Salfi M, Lim JM, Batra VK, Cayen MN, Affrime MB. (2000). Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine. Br. J. Clin. Pharmacol. 50:581-589.
34. Labrecque G, Beauchamp D. (2003). Rhythms and pharmacokinetics. In Redfern PH (ed.) Chronotherapeutics. London, England: Pharmaceutical Press, pp. 75-110.
35. Labrecque G, Belanger PM. (1991). Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol. Ther. 52:95-107.
36. Lemmer B. (1991). Principles and concepts of chronopharmacology: Anti-asthma drugs-cardiovascular agents-H2 blockers. Internist. (Berl.) 32:380-388.
37. Lemmer B. (2005). Chronopharmacology and controlled drug release. Expert Opin. Drug Deliv. 2: 667-681.
38. Lemmer B. (2006a). Clinical chronopharmacology of the cardiovascular system: Hypertension and coronary heart disease. Clin. Ter. 157:41-52.
39. Lemmer B. (2006b). The importance of circadian rhythms on drug response in hypertension and coronary heart disease-from mice and man. Pharmacol. Ther. 111:629-651.
40. Lemmer B, Nold G. (1991). Circadian changes in estimated hepatic blood flow in healthy subjects. Br. J. Clin. Pharmacol. 32:627-629.
41. Martin RJ. (1993). Nocturnal asthma: Circadian rhythms and therapeutic interventions. Am. Rev. Respir. Dis. 147(6Pt2):S25-S28.
42. Milano G, Chamorey AL. (2002). Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiol. Int. 19:177-189.
43. Min DI, Chen HY, Fabrega A, Ukah FO, Wu YM, Corwin C, Ashton Ml, Martin M. (1996). Circadian variation of tacrolimus disposition in liver allograft recipients. Transplantation 62:1190-1192.
44. Miyazaki Y, Yatagai M, Imaoka S, Funae Y, Motohashi Y, Kobayashi Y. (1990). Temporal variations in hepatic cytochrome P450 isoenzymes in rats. Annu. Rev. Chronopharmacol. 7:149-153.
45. Nelson W, Tong YL, Lee JK, Halberg F. (1979). Methods for cosinor rhythmometry. Chronobiologia 6: 305-323.
46. Noehr-Jensen L, Damkier P, Bidstrup TB, Pedersen RS, Nielsen F, Brosen K. (2006). The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers. Eur. J. Clin. Pharmacol. 62:437-445.
47. Ohdo S. (2007). Chronopharmacology focused on biological clock. Drug Metab. Pharmacokinet. 22:3-14.
48. Ohdo S, Ogawa N, Song JG. (1995). Chronopharmacological study of acetylsalicylic acid in mice. Eur. J. Pharmacol. 293:151-157.
49. Paton DM, Webster DR. (1985). Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clin. Pharmacokinet. 10:477-497.
50. Portaluppi F, Lemmer B. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940-951.
51. Ramanathan R, Alvarez N, Su AD, Chowdhury S, Alton K, Stauber K, Patrick J. (2005). Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Xenobiotica 35:155-189.
52. Reinberg A. (1992). Concepts in chronopharmacology. Annu. Rev. Pharmacol. Toxicol. 32:51-66.
53. Reinberg A, Smolensky M. (1982). Circadian changes of drug disposition in man. Clin. Pharmacokinet. 7: 401-420.
54. Reinberg A, Smolensky M. (1983). Chronobiology and thermoregulation. Pharmacol. Ther. 22: 425-464.
55. Reinberg A, Lévi F, Smolensky M. (1984). Clinical chronopharmacokinetics. J. Pharmacol. 15(Suppl. 1): 95-124.
56. Satoh S, Tada H, Murakami M, Tsuchiya N, Li Z, Numakura K, Saito M, Inoue T, Miura M, Hayase Y, Suzuki T, Habuchi T. (2006). Circadian pharmacokinetics of mycophenolic acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients. Transplantation 82:486-493.
57. Sauvage FL, Gaulier JM, Lachatre G, Marquet P. (2006). A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum. Ther. Drug Monit. 28:123-130.
58. Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery and chronotherapy. Adv. Drug Deliv. Rev. 59:828-851.
59. Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: Relevance to prevention and treatment of coronary heart disease. Am. Heart. J. 137(4Pt2):S14-S24.
60. Smolensky MH, Hermida RC, Portaluppi F. (2007a). Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol. Int. 24:171-181.
61. Smolensky MH, Lemmer B, Reinberg A. (2007b). Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv. Drug Deliv. Rev. 59:852-882.
62. Takata M, Burioka N, Ohdo S, Fukuoka Y, Miyata M, Endo M, Suyama H, Shimizu E. (2005). Beta2-adrenoceptor agonists induce the mammalian clock gene, hPer1, mRNA in cultured human bronchial epithelium cells in vitro. Chronobiol. Int. 22:777-783.
63. Touitou Y, Touitou C, Bogdan A, Reinberg A, Auzeby A, Beck H, Guillet P. (1986). Differences between young and elderly subjects in seasonal and circadian variations of total plasma proteins and blood volume as reflected by hemoglobin, hematocrit, and erythrocyte count. Clin. Chem. 32: 801-804.
64. Touitou Y, Smolensky MH, Portaluppi F. (2006). Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol. Int. 23:1083-1096.
65. White WB, LaRocca GM. (2002). Chronopharmacology of cardiovascular therapy. Blood Press. Monit. 7: 199-207.
66. Widerhon N, Díaz D, Picco E, Rebuelto M, Encinas T, Carlos Boggio J. (2005). Chronopharmacokinetic study of gentamicin in dogs. Chronobiol. Int. 22:731-739.
67. Yao Z, DuBois DC, Almon RR, Jusko WJ. (2006). Modeling circadian rhythms of glucocorticoid receptor and glutamine synthetase expression in rat skeletal muscle. Pharm. Res. 23:670-679.
68. Yegnanarayan R, Mahesh SD, Sangle S. (2006). Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Chronobiol. Int. 23:1035-1046.
69. Yumibe N, Huie K, Chen KJ, Snow M, Clement RP, Cayen MN. (1996). Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6. Biochem. Pharmacol. 51:165-172.